Altogether, the overall clinical profile of SRD patients, the most extreme case of SPR loss-of-function, strongly suggests that the lack of this enzyme is not associated with major peripheral symptoms owing to the presence of the salvage pathways. The gene discussed is SPR; the disease is dopa-responsive dystonia due to sepiapterin reductase deficiency.